IP Commercialization

We focus on the commercial side of IP — turning trademarks, copyright, and patents into licensing revenue, royalty streams, or assets that can be assigned and financed. We have a particular focus on bridging research to revenue: guiding medical professionals, clinicians, and academic researchers through the commercialization of patents derived from medical and scientific research into market-ready products.

• →Trademark, copyright, and patent registration with DJKI — including patent strategy and prosecution for medical, biotech, and life-sciences inventions.
• →Licensing agreements, royalty structures, and franchise documentation — tailored for clinicians and research institutions where relevant.
• →Spin-off vehicles to hold and commercialize research-derived IP, plus IP assignment and contribution into operating or holding companies.
• →Freedom-to-operate analysis prior to market launch, and enforcement actions when commercialization is being undermined.

Brand owners, content businesses, franchisors, and technology companies — as well as doctors, researchers, hospitals, and universities — looking to monetize, license, or enforce their IP portfolio, including patents arising from medical and academic research.

Handled trademark and copyright registrations with DJKI, advised on patent strategy and licensing, drafted franchise agreements, and structured IP assignments tied to corporate restructurings, M&A transactions, and research commercialization spin-offs.